Stocks
AbbVie (ABBV) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 1.94 | 11.2 | 2.53 | 2.03 | 2.57 | 3.23 | |||
| Changes by years, y/y, % | -51% | +475% | -77% | -20% | +27% | -8.2% | |||
AbbVie. Debt/EBITDA
AbbVie. Debt/EBITDA, changes, %
AbbVie (ABBV) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q1 | LTM ? | |||
| Debt/EBITDA | 2.00 | 2.18 | 2.55 | -0.67 | 3.03 | 3.23 | ||
| Changes by years, y/y, % | -25% | -9% | +17% | -130% | +35% | |||
| Changes by quarters, q/q, % | -11% | +9% | +17% | -126% | -550% | |||
